Brief: Fusen Pharmaceutical Announces Deal To Form JV Co
01/02/2021 14:41
Feb 1 (Reuters) - Fusen Pharmaceutical Company Ltd
1652.HK :
* JIANGXI YONGFENG KANGDE PHARMACEUTICAL & NANJING
KANGCHUANJI
PHARMACEUTICAL TECHNOLOGY ENTER COOPERATION DEAL
* DEAL TO FORM A JV CO FOR DEVELOPMENT OF TWO PHARMACEUTICAL
PRODUCTS
* REGISTERED CAPITAL OF JOINT VENTURE SHALL BE RMB60 MILLION
Source text for Eikon: ID:nHKS4mxLxM
Further company coverage: 1652.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fusen Pharmaceutical
See all newsBrief: Fusen Pharmaceutical Logs HY Loss Attributable RMB13.6 Million
Brief: Fusen Pharmaceutical Says Doxazosin Mesylate Extended-Release Tablets Approved For Marketing In China
Brief: Fusen Pharmaceutical Says Peramivir Injection First Neuraminidase Inhibitor Approved In China For Intravenous Influenza Treatment
Brief: Fusen Pharmaceutical Says Investors To Contribute RMB300 Mln For 34% Stake Subscription Of Henan Fusen Pharmaceutical
Brief: Fusen Pharmaceutical Says Piracetam Injection Approved For Marketing By NMPA